NAVIGATE UPDATED EU GUIDELINES ON RISK MITIGATION FOR FIH & EARLY CLINICAL TRIALS - Munich, Germany
March 08, 2018
Join Us For Complimentary Sessions With PAREXEL Industry Experts
Meet with PAREXEL® and your Pharma colleagues for: Current Principles of Regulatory Evaluation for Early Phase Protocols, a PAREXEL® symposium examining New EMA Guidelines (which became effective on February 1, 2018).
The symposium sessions will be led by pre-clinical, regulatory, and early phase experts within PAREXEL and will provide you with data on today’s challenges and innovations within Early Clinical development.
You will also have the opportunity to pre-schedule one-on-one discussions with our PAREXEL senior experts after lunch.
This symposium is COMPLIMENTARY for members of the biopharmaceutical industry and will be limited to 25 guests so please register soon!
Dr. Matthias Grossmann
Vice President, Principal Consultant, Clinical Pharmacology, MD, PhD
Principal Consulting, PAREXEL Consulting
Scientific Director, QCD, PAREXEL